PRLD - Financial Reports List - Prelude Therapeutics Incorporated - IntrinsicAlpha

Prelude Therapeutics Incorporated PRLD

Healthcare - Biotechnology - NASDAQ - US

$ 0.7987

-1.4 %

$ 45.1 M

Market Cap

-0.48

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	16.82%	13.13%	9.49%
Annual Report	FY	10-K	2024-12-31	0.00%	-4.38%	-5.62%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-5.43%	-2.97%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-14.16%	-14.71%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-19.41%	-17.96%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-57.60%	-11.96%
Annual Report	FY	10-K	2023-12-31	0.00%	-13.51%	-7.07%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-3.72%	-9.80%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-20.34%	-9.97%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	8.10%	3.87%

1